Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization276 mentions
- NVIDIAorganization264 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
Virtue Sirolimus AngioInfusion Balloon
product2 mentionslast seen Nov 9, 2026
Drug delivery angioplasty balloon system for atherosclerotic artery disease.
Relationships 5
- Orchestra BioMed Holdings, Inc.developsVirtue Sirolimus AngioInfusion Balloon99% confidence2 sources
- Virtue Sirolimus AngioInfusion Ballooncomposed ofSirolimusEFR99% confidence2 sources
- Virtue Sirolimus AngioInfusion Balloonapplies toatherosclerotic artery disease treatment92% confidence1 source
- Virtue Sirolimus AngioInfusion Balloonapplies tocoronary in-stent restenosis92% confidence1 source
- Virtue Sirolimus AngioInfusion Balloonapplies toatherosclerotic artery disease87% confidence1 source
Relationship
Orchestra BioMed Holdings, Inc.developsVirtue Sirolimus AngioInfusion Balloon
99% confidence2 supporting mentions
Either name opens that entity’s relationships.
Sources 2
- filingSEC EDGARNov 9, 2026Orchestra BioMed Holdings, Inc. 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 7.01: Regulation FD Disclosure; Item 9.01: Financial Statements and Exhibits
The Company's two flagship product candidates - AVIM Therapy and Virtue SAB - are currently undergoing pivotal clinical trials
- filingSEC EDGAROct 1, 2026Orchestra BioMed Holdings, Inc. 8-K: Item 7.01: Regulation FD Disclosure; Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
The Company's two flagship product candidates, Atrioventricular Interval Modulation (AVIM) Therapy and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB), are currently undergoing pivotal clinical trials